Not every scientist in the United States originally studied in the United States. Many professionals are drawn to the United States for career opportunities. Gizem Donmez currently works and researches in the United States, but she is an experienced international student. Many university students are familiar with studying abroad, but Gizem Donmez spent more than just a semester in a foreign country.
Gizem Donmez completed her undergraduate degree in Turkey, where she is originally from. She attended Middle East Technical University in Turkey from 1996 to 2000. Gizem Donmez decided to leave her home to complete her advanced degrees in Germany. She was accepted into the international master and PhD program of Molecular Biology at Gottingen University in Gottingen, Germany.
In two years, Gizem Donmez completed her master’s degree. After 2002, Gizem Donmez worked on completing her PhD. She successfully graduated with her PhD in molecular biology and biochemistry in 2007.
Gizem Donmez completed one degree in Turkey and her two advanced degrees in Germany. Gizem Donmez was never afraid to travel. She went where she wanted to advance her career as a scientist. After graduating with her PhD, Gizem Donmez was accepted to MIT for her postdoctoral fellowship. Her postdoctoral fellowship was conducted from 2007 to 2011.
Since 2007, Gizem Donmez has conducted research related to neurodegenerative disease in the United States. It was in 2011 that Gizem Donmez was hired as an assistant professor at Tufts University in Boston, Massachusetts. While Gizem Donmez loves her position in Boston, she is aware of the many great universities in Europe and elsewhere. Gizem Donmez encourages people to look outside their own countries for research and educational opportunities. From her own experience, Gizem Donmez can highly recommend Max Planck Institute in Germany. For students interested in molecular biology, she recommends the Max Planck Institute as one of the finest schools of study in Germany.
Gizem Donmez is proud of her work as a scientist. She has devoted her research to neurodegenerative diseases and hopes to discover new treatments for age-related diseases like Alzheimer’s. Gizem Donmez is currently studying the molecules known as sirtuins, which affect systems in the brain. Gizem Donmez conducts her research and study of sirtuins at the Department of Neuroscience at Tufts University School of Medicine in Boston, Massachusetts.
Gizem Donmez was hired and began work for the university in October of 2011. Devoted to her area of research, Gizem Donmez conducted research and published articles based on her research. As of 2013, Gizem Donmez has successfully published 15 science articles. In 2012, Gizem Donmez was awarded the 2012 New Scholar Award in Aging by the Ellison Foundation in recognition to her work with age-related disease.
Gizem Donmez enjoys her position as Assistant Professor of Neuroscience at Tufts University. In the fall of 2013, she will celebrate two full years of work and research at the university’s school of medicine. She joined the university as a tenure track assistant professor after leaving the Massachusetts Institute of Technology. It was at MIT where Gizem Donmez first began studying sirtuins and their role in the brain of mammals.
Gizem Donmez brings plenty of expertise to her role at Tufts University. She hopes her continued work will one day shed light on neurodegenerative diseases, and on possible new treatments to stop diseases such as Alzheimer’s and Parkinson’s. Gizem Donmez hopes her work will lead to advanced treatments during her lifetime and her career.
Gizem Donmez enjoys her position as assistant professor of neuroscience. She knows the work she does daily contributes to the scientific understanding of diseases affecting millions of people. Gizem Donmez hopes more eager students will consider science and research as a career choice because of the many lives they can help and save.
Millions of family members and caregivers suffer silently each year, as they watch family and friends lose themselves to disease. One of the most difficult realizations is that a loved one is losing their cognition and mental stability to a degenerative disease. Many people suffer from neurodegenerative diseases like Alzheimer’s and want to know what causes it, how to prevent it, and how it can be treated.
Gizem Donmez is one professional in the field who is devoting herself to the study of neurodegenerative disease. She not only studies Alzheimer’s, but also diseases like Parkinson’s. More specifically, Gizem Donmez studies the molecules of the brain in relation to the behavior and cause of the disease. The particular molecules she has studied for years are called sirtuins.
Gizem Donmez found it intriguing that so little was known about aging, even though it is a process people inevitably experience during every moment of their lives. In her lab, Gizem Donmez studies aging, disease, and the relation sirtuins play in the process. With a PhD in molecular biology, Gizem Donmez combines her skills and knowledge of biology, biochemistry, genetics, and more to try to develop a possible treatment for neurodegenerative disease, but also understand what happens to the brain as it ages.
While Gizem Donmez has only been studying and conducting research in the topic at Tufts University for a short period of time, her work follows her back to her time at MIT as a postdoctoral fellow. It was in 2011 that Gizem Donmez started her position as assistant professor of neuroscience at Tufts University. In 2012, just one year into her new role, Gizem Donmez was awarded the 2012 New Scholar Award in Aging given by the Ellison Foundation. The award was given for her research, “Investigating the Heat Shock Response in Aging Mammalian Brain.”
Not everyone understands the role of molecules in the body or their chemicals effects on physical and mental health. Many people are unaware of what happens inside of their body until something goes wrong and they require medical treatment. The treatments that we rely on are the result of years of study and research conducted by doctors and scientists. Medical breakthroughs don’t just happen overnight – years of research and study can be spent on a single disease. Gizem Donmez studies the role of molecules in the brain as they relate to diseases like Alzheimer’s and Parkinson’s disease.
Gizem Donmez is an assistant professor at Tufts University. She is part of the Department of Neuroscience for the university’s school of medicine. Prior to joining the university in the fall of 2011, Gizem Donmez was already studying neurodegenerative disease at MIT. At MIT, from 2007 to 2011, she conducted her postdoctoral fellowship. Gizem Donmez’s research was focused on sirtuins and the role they played in neurodegenerative disease.
In mammals, Gizem Donmez explains, there are seven sirtuins. Sirtuins play important roles in age-related diseases in humans and other higher organisms. To conduct her research on the role they play, Gizem Donmez’s lab researches the role of sirtuins in the brain of mammals using mouse genetics, in the hopes of developing therapeutic applications to treat neurodegenerative diseases.
According to Gizem Donmez, while everyone ages, there is still very little known about the aging process. While research is still being conducted, it has already been found that aging is not as simple as was once thought. Aging is genetically regulated, and gene mutations play a role in regulating lifespan. As a scientist, Gizem Donmez studies both the role of sirtuins in neurodegenerative disease, and the aging process as well. She watches and observes the role of sirtuins in an aging brain, different neurodegenerative diseases, and other age-related conditions of the brain. For her studies, Gizem Donmez was awarded the Ellison Foundation’s 2012 New Scholar in Aging award.
People have a tendency to fear the aging process. While young children are often in a hurry to grow up and be recognized as adults, many adults wish to slow the aging process and delay the inevitable. Now, thanks to science, the aging process is becoming less of a mystery and a clearer understanding has been brought to the aging process. Gizem Donmez is one of the many scientists looking at the aging process.
Gizem Donmez’s focus on aging is narrowed to the brain. Her role as a doctor at the Department of Neuroscience at Tufts University School of Medicine is studying the affect molecules have on the aging brain. She specifically looks at the role sirtuins play in relation to neurodegenerative diseases and other age-related conditions of the brain. While Gizem Donmez only joined the university’s department of neuroscience in 2011, she has already published several articles, and was honored for her work in 2012.
It was in 2012 that Gizem Donmez was awarded the New Scholar Award in Aging. The award was given to Gizem Donmez by the Ellison Medical Foundation, which is a nonprofit corporation. Gizem Donmez received the award for her work, “Investigating the Heat Shock Response in Aging Mammalian Brain.” As a nonprofit corporation, the Ellison Medical Foundation supports research on aging to understand lifespan development and age-related diseases and disabilities.
As a researcher, Gizem Donmez’s research is directly linked to the goals of the Ellison Medical Foundation. Gizem Donmez hopes her research into sirtuins and the role they play in neurodegenerative diseases will lead to development of treatments for age-related degenerative diseases of the brain. Gizem Donmez had only been conducting research at Tufts University for about a year at the time she received the award. Gizem Donmez was honored with the new scholar award and looks forward to many more years researching and understanding neurodegenerative diseases.
Gizem Donmezis familiar with many of the roles she plays as a researcher and scientist today. In the fall of 2011, Gizem Donmez was hired as an assistant professor at Department of Neuroscience at Tufts University School of Medicine. Her role is researching age-related neurodegenerative diseases. For the past several years, Gizem Donmez’s work has focused on the role of sirtuins as they relate to neurodegenerative diseases in higher organisms such as mammals.
Gizem Donmez is not native to Massachusetts or the United States. Originally, Gizem Donmez started her career as a student in Turkey. She only spent her undergraduate years in Turkey before completing her master’s and PhD in molecular biology in Germany. However, as a scientist in Massachusetts, Gizem Donmez was invited to participate in the Science and Engineering Diaspora Engagement in February of 2013. The engagement was held by NODES, which is a partnership between the U.S. Department of State, the American Association for the Advancement of Science, the National Academy of Sciences, and the National Academy of Engineering.
Gizem Donmez attended the event in February because it supports a network of experts who all originate from countries or regions outside the United States. The event builds partnerships and cooperation across the countries which participants are from.
In June of 2013, Gizem Donmez attended and participated in the Targeting Parkinson’s Disease Symposium. Gizem Donmez gave a short presentation at the symposium regarding her own work in relation to sirtuins and their relation to neurodegenerative diseases. The conference was held to discuss both the disease and the unmet need for Parkinson’s treatment.
Gizem Donmez attended both functions in 2013 as a result of her growing recognition and professional role as a researcher. Her knowledge and expertise is recognized by various government organizations and the scientific community. Between 2012 and 2013, Gizem Donmez has eight published articles about her research.